Anupam Rasayan Q1 FY27: Revenue up 35% to ₹655 cr

Results snapshot: strong revenue, softer margins

Anupam Rasayan India Ltd reported its unaudited financial results for the first quarter of FY27, the period ended June 30, 2026. The company delivered a sharp year-on-year rise in consolidated revenue from operations, reflecting stronger top-line traction compared with the same quarter last year. Profit also increased on a year-on-year basis, although operating margin moderated, suggesting costs rose faster than revenue. The update sets the near-term narrative around growth versus profitability, especially as specialty chemical companies balance volumes, pricing, and input costs.

Consolidated revenue rises to ₹654.98 crore

For Q1 FY27, consolidated revenue from operations came in at ₹654.98 crore (₹6,549.80 million). This was a 34.7% to 35% year-on-year increase from ₹485.83 crore (₹4,858.27 million) in the corresponding quarter. The company’s reported numbers highlight that revenue growth was the standout feature of the quarter. Some market summaries also referenced a consolidated revenue figure of ₹667.50 crore (₹6,675 million), but the detailed revenue from operations figure cited in the results text was ₹654.98 crore.

Net profit grows YoY, but slips versus Q4 FY26

Consolidated net profit attributable to owners rose 13.5% year-on-year to ₹38.64 crore (₹386.39 million), compared with ₹34.04 crore (₹340.36 million) in Q1 FY25. The same profit line was described as down about 11% sequentially from ₹42.65 crore (₹426.50 million) reported for Q4 FY26. That mix points to a quarter where growth remained healthy, but profitability did not fully track the revenue jump on a quarter-on-quarter basis.

EBITDA up 30%, margin contracts to 24.8%

On operating performance, consolidated EBITDA rose 30% year-on-year to ₹162.00 crore (₹1,620 million) from ₹124.00 crore (₹1,240 million) in Q1 FY25. However, the EBITDA margin contracted to 24.8% from 25.6% a year ago. The margin movement indicates the company faced cost pressures even as sales expanded. The results commentary framed this as cost intensity outpacing revenue growth during the quarter.

Standalone performance: modest growth, steady profitability

On a standalone basis, revenue from operations increased to ₹328.81 crore (₹3,288.05 million), up from ₹315.69 crore (₹3,156.94 million) year-on-year. Standalone profit after tax rose to ₹32.01 crore (₹320.06 million) from ₹29.69 crore (₹296.94 million). In addition, basic earnings per share (standalone) was reported at ₹2.81, compared with ₹2.70 in the year-ago quarter. These numbers suggest standalone profitability improved, even though the pace of revenue growth was far lower than the consolidated growth rate.

Comprehensive income rises for the group

The company also reported total comprehensive income for the group at ₹51.49 crore (₹514.93 million), up from ₹47.64 crore (₹476.39 million) a year ago. While comprehensive income includes items beyond the profit and loss statement, the year-on-year increase was highlighted in the reported data. This is an additional datapoint investors often track alongside headline PAT.

Key financials table (all amounts in ₹ crore)

Management update: Ravi Desai appointed COO

Alongside the quarterly update, the company approved the appointment of Ravi Desai as Chief Operating Officer. The appointment is effective August 14, 2026. Such senior operating leadership changes are typically watched for execution focus, especially when companies are scaling production and delivery in specialty chemical portfolios.

Corporate development: Basquevolt LOI for $100 million opportunity

The provided updates also referred to a Letter of Intent signed with Basquevolt for a $100 million opportunity. No additional operational or financial phasing details were included in the supplied information. Still, the mention signals that the company is also pursuing longer-duration opportunities in parallel with quarterly execution.

Earnings call scheduled for August 14, 2026

Anupam Rasayan said it will host an earnings call on Friday, August 14, 2026 at 02:00 PM IST to discuss the unaudited financial results for the quarter ended June 30, 2026. For investors, the call is typically where management addresses the drivers behind the margin movement, the revenue mix, and the near-term operating priorities.

Why these results matter for investors

The quarter’s headline picture is a clear top-line acceleration on a consolidated basis, paired with a modest year-on-year increase in profit. At the same time, the EBITDA margin eased from last year, which keeps attention on cost management and the sustainability of operating leverage. The sequential dip in profit versus Q4 FY26 also adds context to the year-on-year improvement. With an earnings call scheduled and an operating leadership appointment effective the same day, investors are likely to focus on execution commentary and any measurable steps around efficiency.

Conclusion

Anupam Rasayan’s Q1 FY27 update showed 35% year-on-year growth in consolidated revenue to ₹654.98 crore, while consolidated net profit (owners) rose to ₹38.64 crore and EBITDA margin slipped to 24.8%. The company is set to discuss the quarter in its August 14, 2026 earnings call, alongside the COO appointment effective that day.